GE HealthCare Technologies Inc. $GEHC Stock Position Raised by Wellington Grp LLC

Wellington Grp LLC grew its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 68.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 19,890 shares of the company’s stock after acquiring an additional 8,115 shares during the quarter. Wellington Grp LLC’s holdings in GE HealthCare Technologies were worth $1,300,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the business. State Street Corp increased its holdings in shares of GE HealthCare Technologies by 1.6% during the second quarter. State Street Corp now owns 20,861,566 shares of the company’s stock valued at $1,335,349,000 after acquiring an additional 323,090 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC boosted its stake in GE HealthCare Technologies by 13.2% in the 2nd quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 13,455,814 shares of the company’s stock worth $861,307,000 after purchasing an additional 1,571,226 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in GE HealthCare Technologies by 2.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 5,399,439 shares of the company’s stock worth $384,219,000 after purchasing an additional 105,995 shares in the last quarter. Van ECK Associates Corp boosted its stake in GE HealthCare Technologies by 4.1% in the 2nd quarter. Van ECK Associates Corp now owns 4,482,631 shares of the company’s stock worth $286,933,000 after purchasing an additional 177,028 shares in the last quarter. Finally, Trian Fund Management L.P. grew its position in GE HealthCare Technologies by 76,194.4% during the 2nd quarter. Trian Fund Management L.P. now owns 3,085,344 shares of the company’s stock worth $197,493,000 after purchasing an additional 3,081,300 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ:GEHC opened at $83.02 on Monday. GE HealthCare Technologies Inc. has a 52-week low of $58.75 and a 52-week high of $89.77. The stock has a market cap of $37.54 billion, a price-to-earnings ratio of 17.51, a PEG ratio of 2.09 and a beta of 0.65. The company has a quick ratio of 1.01, a current ratio of 1.30 and a debt-to-equity ratio of 0.86. The business has a 50-day moving average price of $70.55 and a 200-day moving average price of $70.11.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last released its earnings results on Wednesday, October 28th. The company reported $1.34 EPS for the quarter, topping analysts’ consensus estimates of $1.20 by $0.14. GE HealthCare Technologies had a return on equity of 20.45% and a net margin of 9.96%. The firm had revenue of $5.51 billion during the quarter, compared to the consensus estimate of $5.35 billion. During the same quarter in the previous year, the company posted $1.07 earnings per share. The company’s revenue was up 7.2% compared to the same quarter last year. Equities analysts predict that GE HealthCare Technologies Inc. will post 5.02 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 13th. Shareholders of record on Friday, October 23rd were paid a dividend of $0.04 per share. This represents a $0.16 annualized dividend and a yield of 0.2%. The ex-dividend date was Friday, October 23rd. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.38%.

Analyst Ratings Changes

Several analysts have weighed in on GEHC shares. Oppenheimer reissued an “outperform” rating on shares of GE HealthCare Technologies in a research report on Thursday, July 30th. Bank of America reaffirmed a “neutral” rating on shares of GE HealthCare Technologies in a report on Thursday, October 29th. Argus lifted their price objective on shares of GE HealthCare Technologies from $85.00 to $110.00 and gave the stock a “buy” rating in a research note on Wednesday, November 11th. Zacks Research raised shares of GE HealthCare Technologies from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 11th. Finally, Needham & Company LLC reissued a “buy” rating and set a $93.00 price objective on shares of GE HealthCare Technologies in a report on Monday, October 5th. Twelve investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $82.17.

Get Our Latest Stock Report on GEHC

About GE HealthCare Technologies

(Free Report)

GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.

Read More

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.